Mccormick & CO INC

Market Movers (8-K)

See all →
NYSE
McCormick & Company announced solid third quarter 2026 results, with net sales up 17.4% and adjusted gross profit margin expansion, while reaffirming its full-year financial outlook.
NYSE
McCormick & Company announced the dismissal of Ernst & Young LLP as its independent auditor, effective upon the filing of its annual report, and the engagement of KPMG LLP.
NYSE
McCormick & Company announces the upcoming resignation of Board Director Anne Bramman, who also chairs the Audit Committee, due to her new executive role at Best Buy.
NYSE
McCormick & Company reported a 16.7% increase in second-quarter net sales and reaffirmed its full-year 2026 financial outlook.
Capital raise
NYSE
McCormick & Company, Inc. announced the appointment of Cindy Hoots, former Chief Digital Officer and CIO of AstraZeneca PLC, to its Board of Directors, effective June 1, 2026.
NYSE
McCormick & Company appoints Andrew Foust as Chief Integration Officer to lead the Unilever foods business combination.

Quarterly Earnings (10-Q)

See all →
NYSE
McCormick & Company reported a 17.4% increase in Q3 2026 net sales, largely due to the McCormick de Mexico acquisition and favorable pricing, though significant special charges impacted operating income.
Worse than expected
Capital raise
NYSE
McCormick & Company reported 16.7% net sales growth in Q2 2026, driven by the consolidation of McCormick de Mexico and ongoing strategic integration efforts.
Capital raise
NYSE
McCormick & Company reports strong first-quarter sales growth driven by acquisitions and favorable pricing, while announcing a transformative merger with Unilever's Foods business.
Capital raise
Better than expected
NYSE
McCormick & Company reported a 2.7% increase in net sales for the third quarter of 2025, alongside a strategic acquisition to boost its ownership in McCormick de Mexico.
Capital raise
NYSE
McCormick & Company reported a 1.0% increase in net sales for the second quarter of 2025, reaching $1,659.5 million, alongside a 5.0% rise in operating income, despite a significant increase in special charges and a higher effective tax rate.
Worse than expected
NYSE
McCormick & Company's first quarter 2025 net sales edged up 0.2% year-over-year, with currency fluctuations impacting overall growth.
Worse than expected

Annual Reports (10-K)

NYSE
McCormick & Company reported a 1.7% net sales increase in 2025, driven by volume and pricing, and projects 13-17% sales growth in 2026, significantly boosted by the McCormick de Mexico acquisition.
Capital raise
NYSE
McCormick & Company's fiscal year 2024 saw modest sales growth and improved operating income, but the company anticipates a slower growth trajectory in 2025 due to currency headwinds and strategic investments.
Worse than expected
NYSE
McCormick & Company's 2023 annual report reveals a 4.9% increase in net sales, primarily due to pricing actions, alongside strategic cost management and investments in future growth.

Insider Trading (Form 4)

See all →
NYSE
Brendan M Foley, Chairman, President & CEO and a Director of Mccormick & Co Inc, received 55 shares of common stock on October 8, 2026.
NYSE
Gavin Hattersley, a Director of Mccormick & Co Inc, purchased 1,000 shares of common stock on October 2, 2026 for $44.61 per share.
NYSE
Brendan M Foley, Chairman, President & CEO and a Director of Mccormick & Co Inc, received 51 shares of common stock on September 23, 2026.
NYSE
McCormick & Company outlines its strategic vision for global flavor leadership through the acquisition of Unilever Foods, detailing integration plans, synergy targets, and a strengthened financial outlook.
NYSE
McCormick & Company announces definitive agreement to acquire Unilever's global spreads business for $7 billion, aiming to expand its flavor portfolio and global reach.
Capital raise
NYSE
Andrew Foust, Chief Integration Officer of Mccormick & Co Inc, reported multiple transactions in common stock on July 20, 2026.

Proxy Statements (Def-14A)

NYSE
McCormick & Company, Incorporated has filed a definitive proxy statement with the SEC.
NYSE
McCormick & Company will hold its 2025 Annual Meeting virtually on March 26, 2025, and has released details on director nominees and executive compensation for fiscal year 2024.

Schedule 13D - Activist Investments

NYSE
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Inc., has amended his Schedule 13D filing to report transactions including the sale of 125,385 shares and the exercise and sale of 205,538 shares.
NYSE
McCormick & Company's Chairman, President, and CEO, Brendan M. Foley, reported beneficial ownership of 5.1% of the company's Common Stock, primarily through equity compensation.
NYSE
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, reported an increased beneficial ownership of 11.8% of the company's common stock, including recent option exercises and sales.
NYSE
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Incorporated, has updated his beneficial ownership, reporting a 12.9% stake in the company's Common Stock.

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has reported beneficial ownership of 19,099,707 shares, representing 7.53% of McCormick & Co Inc's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.47% of McCormick & Co. Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group, Inc. has filed an amended Schedule 13G, reporting 0% beneficial ownership of McCormick & Co Inc/MD common stock following an internal corporate realignment.